Company Filing History:
Years Active: 2013
Title: Scott Baskerville: Innovator in Micro-RNA Inhibition
Introduction
Scott Baskerville is an accomplished inventor based in Louisville, Colorado. He has made significant contributions to the field of molecular biology, particularly in the area of cancer research. His innovative work focuses on the inhibition of micro-RNA clusters, which has important implications for breast cancer treatment.
Latest Patents
Scott Baskerville holds a patent for the "Screening of micro-RNA cluster inhibitor pools." This patent outlines methods for inhibiting the activity of a miRNA cluster in a cell. It also describes techniques for screening a cell for phenotypes of interest resulting from the inhibition of a miRNA cluster. The methods utilize a cluster pool that includes at least one miRNA inhibitor specific for each miRNA in the cluster. Notably, the miRNA inhibitors described in the patent can induce apoptosis in breast cancer cells, making them valuable for breast cancer treatment. The patent also covers pharmaceutical compositions useful for treating breast cancer, methods for inducing nuclear translocation of NF-κB and c-Jun in breast cancer cells, and methods for providing prognostic medical information related to breast cancer progression. Scott has 1 patent to his name.
Career Highlights
Throughout his career, Scott has worked with notable companies such as Dharmacon, Inc. and GE Healthcare. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Scott has had the opportunity to work alongside talented individuals, including Anja Smith and Devin Leake. Their collaborative efforts have further advanced the research and development of innovative solutions in cancer treatment.
Conclusion
Scott Baskerville is a pioneering inventor whose work in micro-RNA inhibition has the potential to transform breast cancer treatment. His contributions to the field highlight the importance of innovation in medical research and the ongoing fight against cancer.